SERMs are developed in HRT in order to provide the beneficial effects of estradiol on bone and the cardiovascular system. SERMs are antiestrogens and their properties depend upon the pharmacological class they belong to. Tibolone is a progestin with mixed properties. Our studies on breast cells in vitro demonstrated that it behaves as a progestin in these cells. The clinical data obtained with these various therapies on breast are presented.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[action serm
4
serm sas
4
sas tibolone
4
tibolone breast
4
breast tissue]
4
tissue] serms
4
serms developed
4
developed hrt
4
hrt order
4
order provide
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!